Use caution Drug recall · FDA · Published February 19, 2021

Jubilant Cadista Recalls Methylprednisolone Tablets Due to Labeling Issues

Jubilant Cadista recalls specific lots of Methylprednisolone Tablets USP due to illegible dosing instructions on blister packs.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #D-0298-2021Drug Jubilant Cadista ›

Use caution until it’s fixed

Labeling: Illegible label: Customer complaint received of mis-alignment print of the printed dosing instructions on the blister card.

Take action

Contact the company

Recalling firmJubilant Cadista Pharmaceuticals, Inc.207 Kiley Dr · Salisbury, MD 21801-2249

✎ GovInfoNow plain-language explainer

Jubilant Cadista Pharmaceuticals, Inc. is recalling Methylprednisolone Tablets USP, 4 MG because the printed dosing instructions on the blister card may be misaligned and illegible. This recall affects 635,400 cartons distributed nationwide. The issue stems from customer complaints regarding print alignment. Read more at govinfonow.com/recall/36501-jubilant-cadista-recalls-methylprednisolone-tablets-due-to-labeling-issues.

Source Summary by GovInfoNow · govinfonow.com/recall/36501-jubilant-cadista-recalls-methylprednisolone-tablets-due-to-labeling-issues · Updated October 11, 2026 · FDA enforcement record: FDA #D-0298-2021

Cite this page

“Jubilant Cadista Recalls Methylprednisolone Tablets Due to Labeling Issues.” GovInfoNow, updated October 11, 2026. https://govinfonow.com/recall/36501-jubilant-cadista-recalls-methylprednisolone-tablets-due-to-labeling-issues. Based on FDA recall #D-0298-2021 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0298-2021%22&limit=1).

Jubilant Cadista Pharmaceuticals, Inc. recalled Methylprednisolone Tablets USP, 4 MG on Feb. 19, 2021, due to illegible labeling, the FDA said. The recall affects 635,400 cartons distributed nationwide.

How to tell if you have it

Brand: Jubilant Cadista
Product: Methylprednisolone Tablets USP, 4 MG
Packaging: 21-count blister pack
NDC: 59746-001-03
Lot codes: 20K0043P, 20K0044P, 20K0042P (Exp 08/2022); 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P (Exp 09/2022)
Distribution: USA nationwide, including Puerto Rico

The hazard

The hazard is illegible labeling caused by mis-aligned print of the dosing instructions on the blister card, according to a customer complaint. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show Jubilant Cadista Pharmaceuticals, Inc. has had 24 other recalls since Feb. 11, 2013. Other recent recalls of similar products include Greenstone Methylprednisolone Tablets Recall (Jan. 15, 2026), American Regent Levocarnitine Injection Recall (April 16, 2026), and American Health Packaging Buprenorphine Tablets Recall (Aug. 19, 2026).

How to tell if you have this one

Check if you have Methylprednisolone Tablets USP, 4 MG packaged in a 21-count blister pack with NDC 59746-001-03. Verify the lot numbers: 20K0043P, 20K0044P, 20K0042P (Exp 08/2022) or 20L0026P, 20L0027P, 20L0028P, 20L0029P, 20L0030P (Exp 09/2022).

Brand
Jubilant Cadista
Category
Drug

Based on the official FDA remedy

What to do — step by step

Check Your Medication
Verify if your Methylprednisolone Tablets match the recalled lot numbers and expiration dates listed in the record.
Contact Your Pharmacist
If you have the affected product, contact your pharmacist or healthcare provider for guidance on replacement or return.

Where it went and when

Where it was distributed

Distributed nationwide.

FDA distribution: “USA nationwide, including Puerto Rico.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 21 months after the firm started it.

Feb 19, 2021Firm started the recall
Mar 4, 2021FDA classified it Class III
Mar 10, 2021Published in FDA’s Enforcement Report
Nov 15, 2022FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Where was this product sold?

The product was distributed nationwide in the USA, including Puerto Rico.

Similar recalls

Latest drug recalls

Keep exploring

Link to this recall

<a href="https://govinfonow.com/recall/36501-jubilant-cadista-recalls-methylprednisolone-tablets-due-to-labeling-issues">Jubilant Cadista Recalls Methylprednisolone Tablets Due to Labeling Issues (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #D-0298-2021 (February 19, 2021) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0298-2021 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 11, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.